Health Canada is warning people that unauthorized sexual enhancement products sold in at least three provinces may pose ...

The federal government has been ordered to reassess its 2022 approval of a popular weed-killer after a Federal Court judge ...

Health Canada’s 2022 decision to approve the glyphosate-based herbicide Mad Dog Plus was found to be unreasonable.

The Public Health Agency of Canada (PHAC) and its partners are taking proactive measures to protect the health of people in ...

Approved by Health Canada, Kabrita’s gentle, easy-to-digest infant formula is ideal for all healthy term babies 0-12 months ...

Indaptus Therapeutics (INDP) announced the Company has received Clinical Trial Authorization from Health Canada to initiate its clinical trial ...

(RTTNews) - Merck (MRK) announced that Health Canada has granted approval for KEYTRUDA, Merck's anti-PD-1 therapy, as a treatment for adult patients with resectable Stage II, IIIA, or IIIB non ...

"Health Canada's approval of iptacopan now provides PNH patients options to assure that they get optimal treatment benefit." The Health Canada approval is based on the Phase III APPLY-PNH trial in ...

Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus” or the “Company”), a clinical-stage biotechnology company pioneering innovative cancer and viral infection treatments, today announced the ...